Michael Morrissey - 13 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2026, 20:49:15 UTC
Prior SEC filing
16 Jan 2026
Next SEC filing
02 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nina Ayer, Attorney in Fact

Key filing fact

Michael Morrissey filed Form 4 for EXELIXIS, INC. (EXEL) on 18 Feb 2026.

Key facts

  • This page summarizes Michael Morrissey's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 8 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Feb 2026, 20:49.

Change

  • Previous filing in this sequence was filed on 16 Jan 2026.
  • Current net transaction value: -$10,978,567.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001202096 Primary reporting owner

MORRISSEY MICHAEL

Relationship
President and CEO, Director
Address
C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA
Signature
/s/ Nina Ayer, Attorney in Fact
Signature date
18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Options Exercise

Transaction value
$10,542,057
Shares
+494,700
Change %
+27%
Price
$21.31
Shares after
2,319,941
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1
EXEL transaction

Common Stock

Tax liability

Transaction value
$16,233,096
Shares
-369,606
Change %
-16%
Price
$43.92
Shares after
1,950,335
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1, F2
EXEL transaction

Common Stock

Tax liability

Transaction value
$5,287,529
Shares
-120,390
Change %
-6.2%
Price
$43.92
Shares after
1,829,945
Date
15 Feb 2026
Ownership
Direct
Footnotes
F1, F3
EXEL transaction

Common Stock

Gift

Transaction value
$0
Shares
-250,736
Change %
-14%
Price
$0.000000
Shares after
1,579,209
Date
17 Feb 2026
Ownership
Direct
Footnotes
F1, F4
EXEL transaction

Common Stock

Gift

Transaction value
$0
Shares
+250,736
Change %
+15%
Price
$0.000000
Shares after
1,965,140
Date
17 Feb 2026
Ownership
By Trust
Footnotes
F4, F5
EXEL transaction

Common Stock

Gift

Transaction value
$0
Shares
-125,094
Change %
-7.9%
Price
$0.000000
Shares after
1,454,115
Date
18 Feb 2026
Ownership
Direct
Footnotes
F1, F6
EXEL transaction

Common Stock

Gift

Transaction value
$0
Shares
+125,094
Change %
+6.4%
Price
$0.000000
Shares after
2,090,234
Date
18 Feb 2026
Ownership
By Trust
Footnotes
F5, F6
EXEL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,728
Date
13 Feb 2026
Ownership
By 401(k)
Footnotes
F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-494,700
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
494,700
Exercise price
$21.31
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Footnote F2

Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on January 13, 2026 of $43.92.

Footnote F3

Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

Footnote F4

On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

Footnote F5

Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

Footnote F6

On February 18, 2026, the Reporting Person gifted 125,094 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

Footnote F7

Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.

Footnote F8

The option, representing the right to purchase a total of 494,700 shares of Common Stock, became fully exercisable on March 4, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .